144 related articles for article (PubMed ID: 8080393)
1. Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring.
van Hilten B; Hoff JI; Middelkoop HA; van der Velde EA; Kerkhof GA; Wauquier A; Kamphuisen HA; Roos RA
Arch Neurol; 1994 Sep; 51(9):922-8. PubMed ID: 8080393
[TBL] [Abstract][Full Text] [Related]
2. Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson's Disease.
Schaeffer E; Vaterrodt T; Zaunbrecher L; Liepelt-Scarfone I; Emmert K; Roeben B; Elshehabi M; Hansen C; Becker S; Nussbaum S; Busch JH; Synofzik M; Berg D; Maetzler W
J Neurol; 2021 Jul; 268(7):2506-2514. PubMed ID: 33544218
[TBL] [Abstract][Full Text] [Related]
3. Time for a strategy in night-time dopaminergic therapy? An objective sensor-based analysis of nocturnal hypokinesia and sleeping positions in Parkinson's disease.
Sringean J; Anan C; Thanawattano C; Bhidayasiri R
J Neurol Sci; 2017 Feb; 373():244-248. PubMed ID: 28131197
[TBL] [Abstract][Full Text] [Related]
4. Nocturnal activity and immobility across aging (50-98 years) in healthy persons.
van Hilten JJ; Middelkoop HA; Braat EA; van der Velde EA; Kerkhof GA; Ligthart GJ; Wauquier A; Kamphuisen HA
J Am Geriatr Soc; 1993 Aug; 41(8):837-41. PubMed ID: 8340562
[TBL] [Abstract][Full Text] [Related]
5. Sleep disorders in Parkinson's disease.
Stocchi F; Barbato L; Nordera G; Berardelli A; Ruggieri S
J Neurol; 1998 May; 245 Suppl 1():S15-8. PubMed ID: 9617717
[TBL] [Abstract][Full Text] [Related]
6. Assessment of response fluctuations in Parkinson's disease by ambulatory wrist activity monitoring.
van Hilten JJ; Kabel JF; Middelkoop HA; Kramer CG; Kerkhof GA; Roos RA
Acta Neurol Scand; 1993 Mar; 87(3):171-7. PubMed ID: 8475685
[TBL] [Abstract][Full Text] [Related]
7. Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease.
Chahine LM; Daley J; Horn S; Duda JE; Colcher A; Hurtig H; Cantor C; Dahodwala N
Parkinsonism Relat Disord; 2013 Oct; 19(10):859-63. PubMed ID: 23751512
[TBL] [Abstract][Full Text] [Related]
8. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
[TBL] [Abstract][Full Text] [Related]
9. Pain Correlates with Sleep Disturbances in Parkinson's Disease Patients.
Fu YT; Mao CJ; Ma LJ; Zhang HJ; Wang Y; Li J; Huang JY; Liu JY; Liu CF
Pain Pract; 2018 Jan; 18(1):29-37. PubMed ID: 28371220
[TBL] [Abstract][Full Text] [Related]
10. Sleep in older women with Parkinson's disease.
Dowling GA
J Neurosci Nurs; 1995 Dec; 27(6):355-7, 360-2. PubMed ID: 8770780
[TBL] [Abstract][Full Text] [Related]
11. Continuous quantitative monitoring of physical activity in Parkinson's disease patients by using wearable devices: a case-control study.
Cai G; Huang Y; Luo S; Lin Z; Dai H; Ye Q
Neurol Sci; 2017 Sep; 38(9):1657-1663. PubMed ID: 28660562
[TBL] [Abstract][Full Text] [Related]
12. Dopamine agonists and sleep in Parkinson's disease.
Cantor CR; Stern MB
Neurology; 2002 Feb; 58(4 Suppl 1):S71-8. PubMed ID: 11909988
[TBL] [Abstract][Full Text] [Related]
13. [Pathophysiology, clinical aspects and therapy of sleep disorders in Parkinson disease].
Högl B; Wetter TC; Trenkwalder C
Nervenarzt; 2001 Jun; 72(6):416-24. PubMed ID: 11433700
[TBL] [Abstract][Full Text] [Related]
14. Hypokinesia in Parkinson's disease: influence of age, disease severity, and disease duration.
van Hilten JJ; Braat EA; van der Velde EA; Middelkoop HA; van Dijk JG; Lighart GJ; Roos RA
Mov Disord; 1995 Jul; 10(4):424-32. PubMed ID: 7565821
[TBL] [Abstract][Full Text] [Related]
15. Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease.
Liguori C; Mercuri NB; Albanese M; Olivola E; Stefani A; Pierantozzi M
J Neurol; 2019 Mar; 266(3):636-641. PubMed ID: 30607535
[TBL] [Abstract][Full Text] [Related]
16. Age, drugs, or disease: what alters the macrostructure of sleep in Parkinson's disease?
Sixel-Döring F; Trautmann E; Mollenhauer B; Trenkwalder C
Sleep Med; 2012 Oct; 13(9):1178-83. PubMed ID: 22841842
[TBL] [Abstract][Full Text] [Related]
17. Sleep disorders and their determinants in multiple system atrophy.
Ghorayeb I; Yekhlef F; Chrysostome V; Balestre E; Bioulac B; Tison F
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):798-800. PubMed ID: 12023429
[TBL] [Abstract][Full Text] [Related]
18. Ambulatory activity monitoring during sleep: an evaluation of internight and intrasubject variability in healthy persons aged 50-98 years.
van Hilten JJ; Braat EA; van der Velde EA; Middelkoop HA; Kerkhof GA; Kamphuisen HA
Sleep; 1993 Feb; 16(2):146-50. PubMed ID: 8446834
[TBL] [Abstract][Full Text] [Related]
19. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease and sleepiness: an integral part of PD.
Arnulf I; Konofal E; Merino-Andreu M; Houeto JL; Mesnage V; Welter ML; Lacomblez L; Golmard JL; Derenne JP; Agid Y
Neurology; 2002 Apr; 58(7):1019-24. PubMed ID: 11940685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
